DearJohn replied the topic: Cannabis Wheaton TSXV:CBW
In Globe and Mail this Saturday
- the hot market for Canadian pot plays has all the hallmarks of the boom times in junior mining, when unproven companies attracted big valuations, insiders loaded up on stocks for pennies ahead of deals and investment bankers took personal interests in companies they advised. The Globe's Andrew Willis writes that Bay Street is all abuzz on Cannabis Wheaton Income ($1.17), which provides cash to start-up grow-ops in exchange for a slice of future sales. It has struck streaming deals with 14 fledgling pot producers. In the past two months, Cannabis Wheaton's stock soared from pennies to more than $3 as it pitched its plan to investors, raising money in deals led by Eight Capital and Canaccord Genuity. Brokers at both firms loaded up on shares and warrants at prices of less than three cents. "Representatives" at the two brokerages own 13.1 million shares and the same number of warrants. Mr. Willis notes Cannabis Wheaton's business plan is unproven. The upstart producers it is backing will face competition from proven, deep-pocketed rivals. The fast-money crowd that fuelled the boom and bust in junior mining is now up to its eyeballs in this "high-risk" sector.
Gambler replied the topic: Cannabis Wheaton TSXV:CBW
Another partner for CBW is Harvest One TSX:HVST currently over $60M market cap. They have current grow facilities on Vancouver Island and Saskatchewan
CBW will provide all necessary financing to complete the construction of the Lucky Lake facility and provide sufficient working capital for its initial operations; in consideration for doing so, it will receive 49 per cent of the equity of United Greeneries Saskatchewan Ltd. (UGS) and 40 per cent of the production yield generated by the Lucky Lake facility at a price per gram equal to the cost of production plus 10 per cent.
Cannabis Wheaton Income Corp. has appointed Sarah Bain as vice-president, external affairs, effective today.
Ms. Bain is an expert communications strategist with more than 15 years combined experience in politics, stakeholder relations and public engagement. She has provided advice to cabinet ministers, the Liberal Party of Canada, federal and municipal governments, and leading corporations and associations, such as Loblaw Companies Ltd., National Access Cannabis and the Saskatchewan Association of Rural Municipalities.
Most recently, she was vice-president, public and corporate affairs, at Hill+Knowlton, where she provided strategic advice regarding medical cannabis and the emerging regime of legalized cannabis. She was registered to lobby the government regarding policies and regulations relating to the distribution of medical cannabis, and helped her clients understand Health Canada guidelines and the legislative process as Canada moves toward implementation of the Cannabis Act.
Chuck Rifici noted: "Over the last few years as the Canadian government has introduced legislation to legalize cannabis, Sarah has advocated and engaged with the government, as well as media and stakeholders, on behalf of leading Canadian companies and associations. Cannabis Wheaton and its streaming partners will greatly benefit from the breadth and depth of her Rolodex of relationships, as well as her strategic network, as this country enters a recreational cannabis market."
Cannabis Wheaton is also pleased to announce that it has engaged Skanderbeg Capital Advisors Inc. to provide investor relations and other advisory services to the company.
WealthyPlumber replied the topic: Cannabis Wheaton TSXV:CBW
Anyone dig much into CBW's partner Beleave, trades under symbol BE and has about $60M market cap, the stock has done well moving up in the past several months.
CBW will have a 49% interest in BEs new grow facility
2017-05-19 15:31 ET - News Release
Mr. Chuck Rifici reports
CANNABIS WHEATON CONGRATULATES ITS PARTNER BELEAVE INC.
First Access Medical Inc., the wholly owned subsidiary of Cannabis Wheaton Income Corp.'s partner Beleave Inc., has been granted a cultivation licence under the access to cannabis for medical purposes regulations (ACMPR). Beleave becomes Cannabis Wheaton's fifth licensed producer (LP) partner.